
We’re proud to announce that Seva has been selected by the U.S. Food and Drug Administration (FDA) to participate in the Total Product Life Cycle Advisory Program (TAP) Pilot. TAP is a voluntary program designed to facilitate more efficient development and approval of medical devices.
Continue reading